TEL: 044-952-0102


3D Cell Culture Trends 2013

発行 HTStec Ltd 商品コード 225420
出版日 ページ情報 英文 58 Pages
納期: 即日から翌営業日
本日の銀行送金レート: 1USD=111.84円で換算しております。
Back to Top
3D細胞培養の動向 3D Cell Culture Trends 2013
出版日: 2013年07月17日 ページ情報: 英文 58 Pages


  • エグゼクティブサマリー
  • 目次
  • 調査方法
  • 回答者の主なグループ活動・回答
  • 回答者の国籍
  • 回答者の所属する企業または組織
  • 回答者の職務役割
  • 回答者の主な関心領域
  • 3D細胞培養の現在の導入レベル
  • 培養生成において回答者の関心が最も高い3D構造のタイプ
  • 3D細胞培養の主な用途
  • 3D細胞培養に関する見解
  • 3D細胞培養のもっとも重要なメリット
  • 3D細胞培養の効果を発揮するアプローチ
  • 3D培養基材/フォーマットの適合要件
  • 3D培養にもとめられる各種培養基材
  • 調査結果サマリー(1)
  • 3D細胞培養に利用中の細胞の種類
  • 3D細胞培養に利用予定の細胞の種類
  • 3D細胞培養のアッセイ・プロジェクトの規模
  • 3Dマトリクスを用いた3Dウェルの年間セットアップ総数
  • これまで3D細胞培養を用いたHTS/一次スクリーンを実行したことのある回答者
  • 3D細胞培養への最大の影響因子
  • 3D細胞培養マトリクスでの証明が成功したアッセイタイプ
  • 3D細胞培養での適用が成功した分析技術
  • 3D細胞培養オブジェクトの既存のプレートリーダー/画像システムレートの様相
  • 3D細胞培養で自動化する最重要タスク・自動化への課題
  • 3D細胞培養の自動化への見解
  • 3D細胞培養のアウトソーシングへの関心
  • 3D関連製品・サービスの購入への関心
  • 一番に思い浮かぶアセット対応3D構成・アウトソースサービスベンダー
  • 3D器官型マイクロ組織モデルにおける1次的関心
  • 3D器官型マイクロ組織モデルにおける2次的関心
  • 調査結果サマリー(2)
  • 現在の3D細胞培養による成功達成レベル
  • 3Dマトリクス導入の主な障壁
  • 3D細胞培養は最大限の市場潜在力に達しているか?
  • 3D細胞培養消耗品vs.その他の細胞培養への支出
  • 3D培養関連消耗品の年間予算
  • 3D細胞培養消耗品予算の内訳
  • 3D細胞培養関連の消耗品市場の推計
  • 3D細胞培養関連の消耗品:市場推計の内訳
  • 回答者の購入関心が最も高い3D消耗品
  • 一番に思い浮かぶ3D細胞培養のサプライヤー
  • サプライヤーからもっとも多く購入している3D細胞培養の消耗品&機器
  • 3D消耗品・機器市場におけるサプライヤーのシェア推計
  • 3D細胞培養関連機器支出のCapex予算
  • 調査結果サマリー(3)

This market report summarizes the results of HTStec's 3rd industry-wide global web-based benchmarking survey on three dimensional (3D) cell culture technologies carried out in July 2013.

The study was initiated by HTStec as part of its ongoing tracking of this fast moving technology and emerging marketplace, and to update its previous report (published November 2011).

The main objectives of this global benchmarking study were to comprehensively document continuing interest in, experience gained and progress made in applying 3D cell culture technologies in academic research, drug discovery and tissue engineering/regenerative medicine settings, and to understand their future purchasing preferences.

The survey looked at the following aspects of 3D cell culture as practiced to date (2013) and in a few cases as predicted for the future (2015): current level of adoption (% all cell culture wells processed) of 3D cell culture technologies; areas where interest in 3D cell culture is primarily focused; type of 3D structure most interest in generating in culture; main intended applications of 3D cell culture; opinion on statements about 3D cell culture; most important advantages of 3D cell culture; approaches that have demonstrated most promise to date in facilitating 3D cell culture; vessel formats a 3D scaffold/matrix must have compatibility with; requirements for different types of 3D scaffold; different cell types used for 3D cell culture work; number of 3D wells per assay or project; total number of 3D wells per year; whether any high throughput (primary) screens using 3D technologies have been run to date; where 3D cell culture will make the biggest impact over the coming years; assay types successfully demonstrated using cells within a 3D matrix/structure; analytical technologies that have been applied to 3D cell culture today; how aspects of existing plate readers/imaging systems rate for use in the routine assay/detection/ interrogation of 3D cell culture derived structures; the most important tasks to automate in 3D cell culture; opinion on statements related to automating 3D cell culture; awareness of approaches/platforms used for the automation of 3D cell culture and tissue production/fabrication; interest in outsourcing 3D cell culture; interest in purchasing some assay-ready 3D constructs and outsourced 3D services; vendors that first comes to mind when you think of assay-ready 3D constructs and outsourced 3D services; interest in 3D organotypic microtissue models; level of success achieved with 3D cell culture; realistic adoption period for a new 3D scaffold; main barriers to the adoption of a new 3D matrix; whether 3D cell culture has reached its full market potential yet and what is still missing or where are the gaps/limitations in current 3D offerings; the relationship between spending on 3D consumable technologies versus other cell culture spending; budget for 3D cell culture consumables and its breakdown into components; 3D consumables most likely to be purchased in the future; suppliers of consumables and/or instruments that first come to mind and those most purchased from; and budget allocation to purchase new equipment to enable 3D culture.

The main questionnaire consisted of 30 multi-choice questions and 2 open-ended questions. In addition, there were 5 questions related solely to the administration of survey.

The survey collected 154 validated responses, of these 53% provided comprehensive input.

Survey responses were geographically split: 46% Europe; 31% North America; 12% Asia (excluding Japan); 6% Japan; and 5% Rest of World.

Respondents came from 83 University/Research Institute/Not-for-Profit Facilities; 21 Pharma; 15 Biotechs: 9 Other Organizations; 9 Hospitals/Clinics/Medical Schools; 5 Regen Med/Cell Therapy/Tissue Engineering Companies; 4 CROs; 3 Cosmetics Companies; 2 Government/Military/Defense Facilities; 2 Diagnostics Companies; and 1 Biomanufacturing/Bioprocessing Company.

Most survey respondents had a senior job role or position which was in descending order: 22 professors/ assistant professors; 19 research scientists; 18 principal investigators; 16 others; 16 senior scientists/researchers; 11 department heads; 11 lab managers; 10 directors; 9 graduate/PhD students; and 8 post-docs.

Respondents represented labs with the following main activity: 37 cancer research; 31 basic research; 27 drug discovery; 13 tissue/organ engineering; 10 preclinical research/ADME/toxicology; 9 stem cell biology; 8 regenerative medicine; 6 other; 6 cell therapy; 5 clinical research; and 1 developmental biology.

Survey results were expressed as an average of all survey respondents. In addition, were appropriate the data was reanalyzed after sub-division into the following 5 survey groups: 1) Academic Research; 2) Drug Discovery; 3) Tissue Engineering & Regenerative Medicine; 4) Europe; and 5) North America.

The median level of adoption was 30% of all cell culture wells processed involved a 3D technology.

The 3D structure respondents were most interested in generating in cell culture was spheroids.

The main application investigated using 3D cell culture was cancer therapy.

The level of agreement with some statements about 3D cell culture and 3D automation was recorded.

Better mirrors the environment experienced by normal cells in the body was rated the most important advantage of 3D cell culture.

Hydrogel scaffolds were ranked as the approach that had demonstrated most promise to date in facilitating 3D cell culture.

The 3D scaffold format most wanted was compatibility with the 96-well microplate.

The median requirements for 3D scaffolds with different types of properties were recorded.

Greatest use was made of transformed or recombinant cell lines in 3D cell culture work today (2013).

The median typical size of an assay or project in 3D cell culture was 50 assay wells today (2013).

The median number of assay wells setup per year with a 3D matrix was 200 today (2013).

The majority have not run any high throughput (primary) screens using 3D cell culture to date.

Cancer therapy was the application area where 3D cell culture is expected to make the greatest impact.

The assay type most used/investigated in a 3D cell culture matrix today (2013) was cell proliferation and cell viability.

The analytical technologies most applied in 3D culture today (2013) were fluorescence microscopy, brightfield/phase contrast microscopy and plate readers.

All aspects of existing plate readers/imaging systems were at best rated only moderately adequate, suggesting none performed as desired.

Respondent feedback on the most important tasks to automate with 3D cell culture and the challenges they pose for automation were documented.

Of some approaches to the automation of 3D cell culture respondents were most aware of: InSphero's GravityPLUS™ platform; Corning® Costar® ultra-low attachment 96-well plates; Reinnervate's Alvetex® 96-well plates; and 3D Biomatrix's Perfecta3D™384-well plates.

Only a minority of respondents have outsourced 3D cell culture or related activity to date (2013).

Ready-made kits for specific cell-based assays developed within a 3D matrix were the 3D product or service respondents were most interested in accessing.

InSphero most comes to mind when thinking of assay-ready 3D constructs and outsourced services.

The 3D organotypic microtissue models respondents would like to see offered were documented with respect to organ or tissue, source, disease status required, and reasonable price for 96 tissues.

39% of respondents rated their success achieved with 3D cell culture as major (significant improvement).

The median realistic adoption period for a new 3D scaffold was 6-9 months.

Budget constraints - can't afford to change formats, was rated as the main barrier to the adoption of a new 3D matrix.

The majority think that 3D cell culture has not yet reached its full potential, feedback on what is still missing or where there are gaps/limitations in current 3D offerings were documented.

Around half of respondents total cell culture spending was still allocated to 2D cell culture.

The median budget allocated for spending on 3D cell culture consumables today (2013) was $10K-$25K. The biggest proportion of this budget was allocated to hydrogel 3D scaffolds.

A bottom-up model was developed around the respondent's spending on 3D cell culture consumables to estimate the global market. In 2013 this market was estimated to be around $75M. Segmentation and CAGR estimates are given in the full report.

Hydrogel 3D scaffolds (purchased separate of culture vessel) and microplates designed to encourage spheroid generation were the 3D consumables respondents were most interested in purchasing.

BD Bioscience was the supplier of 3D cell culture consumables that first comes to the mind.

The most purchased from 3D cell culture consumables suppliers were BD Bioscience, Corning and InSphero. Combined these 3 suppliers have around 50% market share.

The median budget allocated for spending on 3D cell culture instruments today (2013) was <$5K.

The full report provides the data, details of the breakdown of the responses for each question, its segmentation and the estimates for the future (2015). It also highlights some interesting differences between the survey groups, particularly Academic Research versus Drug Discovery or Tissue Engineering & Regenerative Medicine.

Table of Contents

  • Executive Summary
  • Table of Contents
  • Survey Methodology
  • Main Group Activity & Response of Survey Participants
  • Respondent's Geographic Origin
  • Respondent's Company or Organisational Origin
  • Respondent's Job Role
  • Respondent's Main Area of Interest
  • Current Level of Adoption of 3D Cell Culture Methods
  • Type of 3D Structure Respondents Are Most Interested in Generating in Culture
  • Main Application of 3D Cell Culture
  • Opinion on Statements About 3D Cell Culture
  • Most Important Advantages of 3D Cell Culture
  • Approaches That Have Demonstrated Promise in 3D Cell Culture
  • 3D Scaffold/Format Compatibility Requirement
  • 3D Culture Requiring Different Types of Scaffolds
  • Summary of Survey Findings (1)
  • Current Use of Different Cell Types in 3D Cell Culture
  • Typical Size of an Assay or Project in 3D Cell Culture
  • Total Number of 3D Wells Setup Per Year With a 3D Matrix
  • Respondents Who Have Run Any HTS/Primary Screens Using 3D Cell Culture to Date
  • Biggest Impact of 3D Cell Culture
  • Assay Types Successfully Demonstrated in a 3D Cell Culture Matrix
  • Analytical Technologies Successfully Applied in 3D Cell Culture
  • How Aspects of Existing Plate Readers/Imaging Systems Rate for 3D Cell Culture Objects
  • Most Important Tasks to Automate With 3D Cell Culture & the Challenges They Pose for Automation
  • Opinion on Statements About 3D Cell Culture Automation
  • Use of Some Approaches for 3D Cell Culture Automation (1)
  • Use of Some Approaches for 3D Cell Culture Automation (2)
  • Interest in Outsourcing 3D Cell Culture
  • Interest in Purchasing Some 3D Derived Products or Services
  • Vendors That First Come to Mind for Assay-Ready 3D Constructs & Outsourced Services
  • Primary Interest in 3D Organotypic Microtissue Models
  • Secondary Interest in 3D Organotypic Microtissue Models
  • Summary of Survey Findings (2)
  • Current Level of Success Achieved With 3D Cell Culture
  • Realistic Adoption Period for a New 3D Scaffold
  • Main Barriers to the Adoption of a 3D Matrix
  • Has 3D Cell Culture Reached its Full Market Potential?
  • Spending on 3D Cell Culture Consumables Versus Other Cell Culture Spending
  • 2013 Annual Budget for 3D Culture-Related Consumables
  • Breakdown of 2011 Budget for 3D Cell Culture Consumables
  • Market Estimate for 3D Cell Culture-Related Consumables
  • Breakdown of 3D Cell-Culture Related Consumables Market Estimate
  • 3D Consumables Respondents are Most Interested in Purchasing
  • 3D Cell Culture Suppliers That Comes to Mind (1)
  • 3D Cell Culture Suppliers That Comes to Mind (2)
  • Most Purchased From Suppliers of 3D Cell Culture Consumables & Related Instruments (1)
  • Most Purchased From Suppliers of 3D Cell Culture Consumables & Related Instruments (2)
  • Estimated Supplier Share of 3D Consumables & Instruments Market
  • Capex Budget for 3D Cell Culture-Related Instrument Spending
  • Summary of Survey Findings (3)
Back to Top